Importance Antiretroviral therapy (ART) has improved life expectancy for individuals with HIV
infection, but recent data comparing life span and comorbidity-free years by HIV status are …

Objectives. To determine whether HIV preexposure prophylaxis (PrEP) use is associated
with use of non–HIV-related health care. Methods. We conducted a cross-sectional study of …

Background The limitations of existing HIV risk prediction tools are a barrier to implementation
of pre-exposure prophylaxis (PrEP). We developed and validated an HIV prediction model …

Referrals for and initiation of preexposure prophylaxis (PrEP) for human immunodeficiency
virus (HIV) infection increased dramatically in a large clinical practice setting since 2012. …

Background: It is unknown if a survival gap remains between HIV-infected and HIV-uninfected
individuals with access to care. Methods: We conducted a cohort study within Kaiser …

Methods: We examined the relationship between number of prior rectal Neisseria gonorrhoeae
(GC) or Chlamydia trachomatis (CT) infections and HIV seroconversion in a retrospective …

It is generally agreed that striking a balance between resuming economic and social activities
and keeping the effective reproductive number (R0) below 1 using nonpharmaceutical …

Background: Placebo-controlled and open-label studies have demonstrated the safety and
efficacy of daily oral preexposure prophylaxis (PrEP) in preventing HIV infection, but data are …

Objective Preexposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate (FTC/TDF)
reduced HIV acquisition in the iPrEx trial among men who have sex with men and …

Objective: To determine the association of HIV infection and immunodeficiency with incidence
of ischemic stroke. Design: Cohort study of HIV-positive and matched HIV-negative adult …